Almost 90% of the human genome is transcribed into RNA, but only 3% is ultimately translated into a protein. Some non-translated RNA is thought to be useless, while some play a significant yet often mysterious role in cancer and other diseases. Despite its abundance and biological significance, RNA is rarely the target of therapeutics.
โWe say itโs undruggable, but I would say that โnot-yet-druggedโ is a better way to put it,โ says Amanda Garner, Associate Professor of Medicinal Chemistry at the University of Michigan. โWe know that RNA biology is important, but we donโt yet know how to target it.โ

Amandaโs lab develops systems to study RNA biology. She employs a variety of approaches to analyze the functions of different RNAs and study their interactions with proteins. Her lab recently published a paper describing a novel method for studying RNA-protein interactions (RPI) in live cells. Amanda says that with the right tools, RPI could become a critical target for drug discovery.
โItโs amazing that current drugs ever work, because theyโre all based on really old approaches,โ Amanda says. โThis isnโt going to be like developing a small molecule kinase inhibitor. Itโs a whole new world.โ
Continue reading “RNA-Protein Interactions: A New Frontier for Drug Discovery”








